| Character |
N=95/% |
Chest X-Ray Final Result |
|
COR(95%CI) |
P-Value |
AOR(95%CI) |
P-Value |
| |
|
Normal(n=69) |
Abnormal(n=26) |
|
|
|
| Sex |
| Female |
61(64.2) |
45(73.8%) |
16(26.2%) |
1.2(0.46-2.9) |
0.74 |
|
|
| Male |
34(35.8) |
24(70.5%) |
10(29.4%) |
1 |
|
|
|
| Age |
| ≤40 |
63(66.3) |
49(77.7%) |
14(22.2%) |
1 |
|
|
|
| ≥41 |
32(33.7) |
20(62.5%) |
12(37.5%) |
2.1(0.83-5.3) |
0.12 |
|
|
| Occupation |
| House wife |
22(23.2) |
17(77.2%) |
5(22.7%) |
0.9(0.2-4.5) |
0.88 |
|
|
| Unemployed |
21(22.1) |
11(52.4%) |
10(47.6%) |
2.7(0.57-13) |
0.2 |
|
|
| Private |
32(38.9) |
29(90.6%) |
8(25%) |
0.83(0.2-3.8) |
0.81 |
|
|
| Petty Trader |
3(3.2) |
3(100%) |
0 |
NA |
|
|
|
| Government |
12(12.6) |
9(75%) |
3(25%) |
1 |
|
|
|
| Education |
| Illiterate |
19(20) |
14(73.7%) |
5(26.3%) |
0.71(0.13-4.0) |
0.7 |
|
|
| Literate |
8(8.4) |
5(62.5%) |
3(37.5%) |
1.2(0.16-8.8) |
0.86 |
|
|
| Elementary |
24(25.3) |
16(66.7%) |
8(33.3%) |
1(0.2-5.1) |
1 |
|
|
| Secondary |
35(36.8) |
28(80%) |
7(20%) |
0.5(0.1-2.5) |
0.4 |
|
|
| Higher |
9(9.5) |
6(66.6%) |
3(33.3%) |
1 |
|
|
|
| Marital status |
|
|
|
|
|
|
| Single |
21(22.1) |
15(%71.4) |
6(28.5%) |
1.12(0.23-4.5) |
0.87 |
|
|
| Married |
32(33.7) |
26(81.3%) |
6(18.8%) |
0.6(0.17-2.5) |
0.53 |
|
|
| Separated |
8(8.4) |
6(75%) |
2(25%) |
0.93(0.14-6.2) |
0.94 |
|
|
| Divorced |
15(15.8) |
8(44.4%) |
7(46.7%) |
2.4(0.58-10.3) |
0.22 |
|
|
| Widowed |
19(20) |
14(73.7%) |
5(26.3%) |
1 |
|
|
|
| Drinking |
| Yes |
3(3.2) |
2(66.7%) |
1(33.3%) |
0.75(0.07-8.6) |
0.81 |
|
|
| No |
92(96.8) |
67(72.8%) |
25(27.1%) |
1 |
|
|
|
| Previous TB history |
| Yes |
44(46.3) |
24(54.5%) |
20(45.5%) |
6.2(2.2-17.7) |
0.001 |
9.5(3.0-30.3) |
<0.001 |
| No |
51(53.7) |
45(88.2%) |
6(11.8%) |
1 |
|
|
|
| Close Contact with TB patient |
| Yes |
9(9.5) |
7(77.8%) |
2(22.2%) |
0.74(0.14-3.8) |
0.72 |
|
|
| No |
86(90.5) |
62(72.1%) |
24(27.9%) |
1 |
|
|
|
| HIV stage |
| Stage One |
85(89.5) |
62(72.9%) |
23(27%) |
1 |
|
|
|
| Stage Two |
3(3.2) |
2(66.7%) |
1(33.3%) |
1.3(0.12-15.6) |
0.81 |
|
|
| Stage Three |
6(6.3) |
4(66.7%) |
2(33.3%) |
1.4(0.23-7.9) |
0.74 |
|
|
| Stage Four |
1(1.1) |
1(100%) |
0 |
|
|
|
|
| CD4 count |
| ≤350 |
32(33.7) |
21(65.6%) |
11(34.4%) |
1.7(0.66-4.25) |
0.3 |
|
|
| >350 |
63(66.3) |
48(76.2%) |
15(23.8%) |
1 |
|
|
|
|
